Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 1 Oct 2022

Liao Junqun, Ye Yuan, Xu Xuren

Abstract excerpt

PURPOSE: Prostate adenocarcinoma (PRAD) is a high incidence of malignant tumor of the urinary system and the second most common male cancer in the world. Immune checkpoint inhibitor (ICIS) therapy is becoming a new hope for cancer treatment. METHODS: To realize the possibility of PRAD patients benefiting from ICIS treatment, we analyzed the mutation spectrum of all PRAD patients, calculated the TMB of each PRAD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Immunotherapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Share to Prostatic Neoplasms

Share to Tumor Microenvironment

Source

Identifiers

PMID: 35732871
DOI: 10.1007/s12094-022-02857-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer.PMID 35732871Read ↗

Database Mining of Genes of Prognostic Value for the Prostate Adenocarcinoma Microenvironment Using the Cancer Gene AtlasSemantic proximity Read ↗

Exploration of gene expression profiles and immune microenvironment between high and low tumor mutation burden groups in prostate cancer.Semantic proximity Read ↗

Immune infiltration phenotypes of prostate adenocarcinoma and their clinical implications.Semantic proximity Read ↗

Predicting Prostate Adenocarcinoma Patients’ Survival and Immune Signature: A Novel Risk Model Based on Telomere-Related GenesSemantic proximity Read ↗

The Analysis of Tumor Microenvironment of Prostate Cancer Identifies Prognostic SignaturesSemantic proximity Read ↗

Identification and validation of the pyroptosis-related genes signature based on immune microenvironment and molecular heterogeneity in prostate adenocarcinomaSemantic proximity Read ↗

Screening of tumor antigens and immunogenic cell death landscapes of prostate cancer for exploration of mRNA vaccineSemantic proximity Read ↗

Development of a Novel Immune-Related Prognostic Signature for Prostate CancerSemantic proximity Read ↗

FLG Gene Mutation Up-regulates the Abnormal Tumor Immune Response and Promotes the Progression of Prostate Cancer.Semantic proximity Read ↗

Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccineSemantic proximity Read ↗

Comprehensive Analysis of Cell Cycle-Related Genes in Patients With Prostate CancerSemantic proximity Read ↗

Identification of Prostate Cancer Subtypes Based on Immune Signature Scores in Bulk and Single Cell TranscriptomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.